Washington University School of Medicine led a study evaluating long-term gantenerumab treatment in individuals with ...

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain.

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...

ESK-001, a tyrosine kinase 2 inhibitor, may be a promising new oral treatment for plaque psoriasis. Patients taking ESK-001 twice daily maintained skin clearance up to a year. ORLANDO — Patients ...

DARLINGTON is to get a blue plaque scheme. For more than a decade, the Memories section of The Northern Echo has been calling for the town to mark some of its most fascinating buildings ...

Lt. Gen. Omar Jones, IMCOM commanding general, recognized award recipients with plaques at the Garrison Command Team Conference in San Antonio, Texas on June 4. More than 200 leaders from across ...